Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pykus Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Pykus Therapeutics

Pykus Therapeutics

Seed

Pykus Therapeutics: Innovating less painful, more successful retinal surgeries since 2016.

HQ
Boston, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Pykus Therapeutics, Inc. was founded in 2016 by ophthalmology residents at the Massachusetts Eye and Ear Infirmary and Harvard Medical School. The company's core mission is to innovate retinal surgeries, making them less painful and more successful. Pykus Therapeutics focuses on developing a dissolvable intraocular surgical device, aimed at improving outcomes for patients undergoing retinal surgery. Their market focus is on ophthalmology, specifically targeting retinal specialists and surgical centers.

Notable affiliated individuals include the co-founders who were residents at prestigious institutions. Pykus Therapeutics has garnered attention for its novel approach to retinal tamponade, a critical aspect of retinal surgery. The company’s key achievements include the development of their innovative dissolvable device, which has the potential to significantly impact the field of ophthalmology by reducing patient discomfort and improving surgical success rates.

Pykus Therapeutics - Similar Companies

Iscience Surgical logo

Iscience Surgical

Vortex Surgical logo

Vortex Surgical

vortexsurgical.com

Mobius Therapeutics logo

Mobius Therapeutics

Perfuse Therapeutics logo

Perfuse Therapeutics

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Current Surgical logo

Current Surgical

OcuMedic logo

OcuMedic

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

EyeCyte logo

EyeCyte

eyecyte.com

Nanophthalmics logo

Nanophthalmics

Glaukos logo

Glaukos

glaukos.com

OcuCure Therapeutics logo

OcuCure Therapeutics

Advanced Optronics logo

Advanced Optronics

Prescient Surgical logo

Prescient Surgical

Ocudyne logo

Ocudyne

ocudyne.com

Pykus Therapeutics - Quick Facts

Who are Pykus Therapeutics' competitors?

Companies similar to Pykus Therapeutics include Iscience Surgical, Vortex Surgical, Mobius Therapeutics and Perfuse Therapeutics.

When was Pykus Therapeutics founded?

Pykus Therapeutics was founded in 2016.

Where is Pykus Therapeutics' headquarters located?

Pykus Therapeutics' headquarters is located in Boston, MA, US.

When was Pykus Therapeutics' last funding round?

Pykus Therapeutics' most recent funding round was for $2.5M (USD) in February 2021.

How much has Pykus Therapeutics raised to-date?

As of Feb 4, 2021, Pykus Therapeutics has raised a total of $2.6M (USD).

How many employees does Pykus Therapeutics have?

Pykus Therapeutics has 8 employees as of Feb 5, 2024.

Pykus Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Surgicaldevices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified